Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
OSE-127/Lusvertikimab
FR104/VEL-101
BI 765063
BI 770371
OSE-230
CLEC-1
BiCKI®
Research & Development
Scientific publications
Investors
Press Releases
Regulated information
Financial documents
General Shareholders’ meetings
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
//
Retour aux publications financières
Date
2022 Universal registration document
Téléchargez